Neuroendokrin aktivering ved hjerteinsufficiens II: Kan diagnosen stilles og prognosen vurderes med en blodprove?

Research output: Contribution to journal › Review › Research › peer-review

Standard

Neuroendokrin aktivering ved hjerteinsufficiens II : Kan diagnosen stilles og prognosen vurderes med en blodprove? / Kjaer, A.

In: Ugeskrift for Laeger, Vol. 162, No. 44, 30.10.2000, p. 5910-5913.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Kjaer, A 2000, 'Neuroendokrin aktivering ved hjerteinsufficiens II: Kan diagnosen stilles og prognosen vurderes med en blodprove?', Ugeskrift for Laeger, vol. 162, no. 44, pp. 5910-5913.

APA

Kjaer, A. (2000). Neuroendokrin aktivering ved hjerteinsufficiens II: Kan diagnosen stilles og prognosen vurderes med en blodprove? Ugeskrift for Laeger, 162(44), 5910-5913.

Vancouver

Kjaer A. Neuroendokrin aktivering ved hjerteinsufficiens II: Kan diagnosen stilles og prognosen vurderes med en blodprove? Ugeskrift for Laeger. 2000 Oct 30;162(44):5910-5913.

Author

Kjaer, A. / Neuroendokrin aktivering ved hjerteinsufficiens II : Kan diagnosen stilles og prognosen vurderes med en blodprove?. In: Ugeskrift for Laeger. 2000 ; Vol. 162, No. 44. pp. 5910-5913.

Bibtex

@article{cd050394b024466cb0f01c1bc730e16d,
title = "Neuroendokrin aktivering ved hjerteinsufficiens II: Kan diagnosen stilles og prognosen vurderes med en blodprove?",
abstract = "Neurohumoral systems activated in heart failure are reviewed in relation to prognostic and diagnostic information. Plasma levels of noradrenaline, renin, vasopressin, endothelin-1, ANP, BNP, and TNF-α are all elevated in heart failure. Most of these factors correlate with the prognosis, but only a minor part seems to posses additional, independent information when other information that is normally available in such patients is taken into account. At present, the diagnosis of heart failure cannot be made on only one blood sample. However, neuroendocrine markers seem: 1) to have a role in the diagnosis and classification of heart failure, 2) to be useful in providing a 'neuroendocrine profile', which elucidates different aspects of heart failure, and 3) to be of probable value in the choice and titration of medical treatment for the individual patient in the future.",
author = "A. Kjaer",
year = "2000",
month = oct,
day = "30",
language = "Dansk",
volume = "162",
pages = "5910--5913",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "44",

}

RIS

TY - JOUR

T1 - Neuroendokrin aktivering ved hjerteinsufficiens II

T2 - Kan diagnosen stilles og prognosen vurderes med en blodprove?

AU - Kjaer, A.

PY - 2000/10/30

Y1 - 2000/10/30

N2 - Neurohumoral systems activated in heart failure are reviewed in relation to prognostic and diagnostic information. Plasma levels of noradrenaline, renin, vasopressin, endothelin-1, ANP, BNP, and TNF-α are all elevated in heart failure. Most of these factors correlate with the prognosis, but only a minor part seems to posses additional, independent information when other information that is normally available in such patients is taken into account. At present, the diagnosis of heart failure cannot be made on only one blood sample. However, neuroendocrine markers seem: 1) to have a role in the diagnosis and classification of heart failure, 2) to be useful in providing a 'neuroendocrine profile', which elucidates different aspects of heart failure, and 3) to be of probable value in the choice and titration of medical treatment for the individual patient in the future.

AB - Neurohumoral systems activated in heart failure are reviewed in relation to prognostic and diagnostic information. Plasma levels of noradrenaline, renin, vasopressin, endothelin-1, ANP, BNP, and TNF-α are all elevated in heart failure. Most of these factors correlate with the prognosis, but only a minor part seems to posses additional, independent information when other information that is normally available in such patients is taken into account. At present, the diagnosis of heart failure cannot be made on only one blood sample. However, neuroendocrine markers seem: 1) to have a role in the diagnosis and classification of heart failure, 2) to be useful in providing a 'neuroendocrine profile', which elucidates different aspects of heart failure, and 3) to be of probable value in the choice and titration of medical treatment for the individual patient in the future.

UR - http://www.scopus.com/inward/record.url?scp=0034735418&partnerID=8YFLogxK

M3 - Review

C2 - 11094550

AN - SCOPUS:0034735418

VL - 162

SP - 5910

EP - 5913

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 44

ER -

ID: 283515812